R. Kuhn

Publications84
h-index51
Citations8,271
Highly Influential Citations481
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • F. Nicoletti
  • 979 Publications • 37,513 Citations
  • J. Pin
  • 365 Publications • 30,791 Citations
  • R. Shigemoto
  • 377 Publications • 38,179 Citations
  • P. Flor
  • 98 Publications • 7,995 Citations
  • Publications
  • Influence
2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist
View on Elsevier
A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo.
TLDR
An mGluR7-selective agonist, N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride (AMN082), which directly activates receptor signaling via an allosteric site in the transmembrane domain is characterized and provided evidence for full agonist activity mediated by the heptahelical domain of family 3 G protein-coupled receptors that may lead to drug development opportunities.
View on PubMed
CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding.
TLDR
It is proposed that the interaction of CPCCOEt with Thr815 and Ala818 of mGluR1 disrupts receptor activation by inhibiting an intramolecular interaction between the agonist-bound extracellular domain and the transmembrane domain.
View on PubMed
The Non-competitive Antagonists 2-Methyl-6-(phenylethynyl)pyridine and 7-Hydroxyiminocyclopropan[b]chromen-1a-carboxylic Acid Ethyl Ester Interact with Overlapping Binding Pockets in the…
TLDR
Results indicate that MPEP and CPCCOEt bind to overlapping binding pockets in the TM region of group I mGluRs but interact with different non-conserved residues.
View on Publisher
Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist
TLDR
The data suggest that selective mGlu5 receptor antagonists may play a role in the therapy of anxiety and/or depression, further studies are required to identify the sites and the mechanism of action of MPEP.
View on Wiley
Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents.
TLDR
Findings indicate that MPEP exhibits anxiolytic-like effects and low risks for sedation and psychotomimetic side-effects in rodents.
View on PubMed
(−)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection
View on Elsevier
Mutagenesis and Modeling of the GABAB Receptor Extracellular Domain Support a Venus Flytrap Mechanism for Ligand Binding*
TLDR
A three-dimensional model of the LBP-like domain of the GABAB receptor was constructed based on the known structure of LBP and proposes that the initial step in the activation of the receptor by agonist results from the closure of the two lobes of the binding domain.
View on Publisher
Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis.
View on PubMed
mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia
View on Elsevier
...
...